The wide expression profile and localization of SVEP1 across several tissues and in plasma, and the numerous genetic and aptamer-based proteomic studies provide strong evidence of the involvement of SVEP1 in disease, in particular cardiovascular and metabolic disorders, however the mechanisms underlying these associations remain poorly understood. Here, SVEP1 is linked to metabolic disease.